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Identity 
HGNC (Hugo): TOP1 
Location: 20q12-q13.1 
Location (base pair): 39090K-39190K on 
chromosome 20 
Local order: centromer to telomer. 
DNA/RNA 
Note 
The sequence is split into 21 exons over 85kbp. Introns 
are 0.2-30 kbp in size. 
Description 
21 exons with 20 introns. 
Transcription 
3.8 kb (single band). 
Pseudogene 
2 pseudogenes: TOP1P1 on chromosome 1q23-q24, 
and TOP1P2 on chromosome 22q12-q13.1. 
Protein 
Note 
Type I DNA topoisomerase, EC (5.99.1.2). 
 
 
The arrow indicates the breaking point of translocation, and the 
star denotes the sites of point mutation. 
Description 
765 amino acids, about 100kDa; contains NLS in the 
N-term, a core domain which recognizes its binding 
sequences, a link domain which connects the core and 
catalytic domains, and the catalytic domain in the C-
term. 
Expression 
Ubiquitous. The expression level is up-regulated along 




TOP1 catalyzes the breaking and rejoining of single 
DNA strand. 
Homology 
The core and catalytic domains are conserved between 
the human and S.cerevisiae enzyme. 
 
The star denotes intron 7 where chromosome translocation occurs. 













Translocation of chromosome t(11;20)(p15;q12) has 
been reported in hematological malignancies (see 
below). 
Point mutations with amino acid substitution in the 





de novo acute myeloid leukemia, acute monocytic 







NUP98-TOP1 fusion protein has been proved to have 




The breakpoints locate in intron 7, causing the fusion protein to 
lack the N-terminal 169 amino acids.The breakpoints locate in 
the repetitive elements or close to them which exist in intron 7 
of TOP1 gene. 
To be noted 
Note 
Point mutations W736stop and G737S were detected in 
lung non-small cell carcinoma. The significance of 
mutations in catalytic domain has been suspected to be 
relevant to susceptibility to irinotecan. 
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